ST凯利: 上海凯利泰医疗科技股份有限公司关于公司股票被实施其他风险警示相关事项的进展公告

Group 1 - The company, Shanghai Kelly Medical Technology Co., Ltd., has received a warning regarding its stock due to an audit report from Zhonghua Accounting Firm, which issued an opinion of inability to express an opinion on the internal control of the financial report for the fiscal year 2024 [1][2] - According to the Shenzhen Stock Exchange's rules, the company is subject to risk warnings and may face delisting risk if the issues related to the audit report are not resolved [1][2] - The company has taken measures to address the issues raised in the audit report, including enhancing compliance awareness among board members and management, reviewing related party transactions, and establishing a whistleblower system to reduce fraud opportunities [2][3] Group 2 - The company is required to disclose progress updates at least once a month during the warning period until the issues are resolved or until a delisting risk warning is implemented [3] - The company emphasizes the importance of maintaining the interests of all shareholders, particularly minority shareholders, by improving internal controls and ensuring compliance [3]